Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
11.85
-0.10 (-0.84%)
At close: Apr 28, 2026, 4:00 PM EDT
11.88
+0.03 (0.21%)
After-hours: Apr 28, 2026, 6:37 PM EDT
Kazia Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts that cover Kazia Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $19.5, which forecasts a 64.56% increase in the stock price over the next year. The lowest target is $15 and the highest is $25.
Price Target: $19.5 (+64.56%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +110.97% | Apr 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +51.90% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $18 | Strong Buy | Maintains | $13 → $18 | +51.90% | Dec 12, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +68.78% | Oct 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $13 | Strong Buy | Maintains | $2 → $13 | +9.70% | Jul 10, 2025 |
Financial Forecast
Revenue This Year
190.74K
from 1.83M
Decreased by -89.57%
Revenue Next Year
119.34K
from 190.74K
Decreased by -37.43%
EPS This Year
-0.69
from -18.89
EPS Next Year
-0.57
from -0.69
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 484,050 | 304,500 | ||||||
| Avg | 190,740 | 119,340 | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -73.5% | 59.6% | ||||||
| Avg | -89.6% | -37.4% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.01 | - | ||||||
| Avg | -0.69 | -0.57 | ||||||
| Low | -1.32 | -1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.